CORRESP Filing
Rani Therapeutics Holdings, Inc.
Date: Aug. 12, 2025 · CIK: 0001856725 · Accession: 0001193125-25-178946
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289424
Letter
Re:
RANI THERAPEUTICS HOLDINGS, INC. 2051 Ringwood Avenue San Jose, California 95131 August 12, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C.
Attn:
Chris Edwards
Rani Therapeutics Holdings, Inc.
Registration Statement on Form S-3
File No. 333-289424
Acceleration Request
Requested Date:
August 14, 2025
Requested Time:
4:15 PM Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Rani Therapeutics Holdings, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) and declare the Registration Statement effective as of 4:15 p.m. Eastern Time, on August 14, 2025, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. The Company hereby authorizes each of Josh Seidenfeld and John McKenna of Cooley LLP, counsel to the Company, to make such a request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP at (650) 843-5059. [Signature page follows]
Very truly yours,
Rani Therapeutics Holdings, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP RANI THERAPEUTICS HOLDINGS, INC. 2051 Ringwood Avenue San Jose, California 95131 August 12, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards Re: Rani Therapeutics Holdings, Inc. Registration Statement on Form S-3 File No. 333-289424 Acceleration Request Requested Date: August 14, 2025 Requested Time: 4:15 PM Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Rani Therapeutics Holdings, Inc. (the “ Company ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) and declare the Registration Statement effective as of 4:15 p.m. Eastern Time, on August 14, 2025, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. The Company hereby authorizes each of Josh Seidenfeld and John McKenna of Cooley LLP, counsel to the Company, to make such a request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP at (650) 843-5059. [Signature page follows] Very truly yours, Rani Therapeutics Holdings, Inc. /s/ Svai Sanford By: Svai Sanford Title: Chief Financial Officer cc: Josh Seidenfeld, Cooley LLP John McKenna, Cooley LLP [Signature Page to Acceleration Request]